Tag Archive for: mdma

Mind Cure Health Halts All Psychedelic Business ActivityShutterstock

Mind Cure Health Halts All Psychedelic Business Activity

,
The company was pursuing several psychedelic business strategies, including synthesizing ibogaine for researchers.
Top 5 Most Influential Psychedelic StudiesShutterstock

Top 5 Most Influential Psychedelic Studies

We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine.
How Long Until Psychedelic Stocks Payoff?Shutterstock

How Long Until Psychedelic Stocks Payoff?

,
Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing in psychedelic stocks.
How MAPS Founder Rick Doblin Guides Someone Through a Bad Psychedelic TripShutterstock

How Rick Doblin Guides Someone Through a Bad Psychedelic Trip

Difficult trips could be a problem in areas where psychedelics have been decriminalized, which is why MAPS will offer a psychonaut training program.
Psychedelic Business Spotlight - January 21

Psychedelic Business Spotlight – January 21

,
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds

Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds

Americans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety, and PTSD.
Health Canada Grants Special Access to Restricted Drugs for Psychedelic TherapyShutterstock

Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy

New amendment reverses a 2013 Health Canada policy that prevented "a letter of authorization for a new drug that is or that contains a restricted drug."

2021: A Year in Review for the Psychedelics Business

Our resident Psychedelic Investor looks back at some of this growing industry's biggest moments and how they may shape the business in 2022.

Texas Further Embraces Psychedelics with Launch of Center for Psychedelic Research and Therapy

Research will focus on how various psychedelics can be used under proper supervision and guidance to treat severe depression, anxiety and PTSD.
Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications

Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications

Psychedelic Spotlight speaks to a Field Trip Health patient and a psychotherapist, whose experiences suggest ketamine can also treat anxiety among other mental health issues.